GP BC Partners, Canadian pension fund PSP Investments and other minority co-investors have sold their stakes in France-based Antelliq (formerly Allflex), a devices provider for animal identification and traceability, to US-based Merck in a deal valued at more than €3bn.
Backers close a $18.6m round started in 2015 with an initial $10.6m capital injection
GP invests via its Nordic Capital Fund IX, which held a final close on €4.3bn in May 2018
Abalos Therapeutics is a biotechnology company focused on developing immuno-oncology therapeutics
Existing management team will lead the company's future growth and development